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Sunday, March 1, 2009 111ato sham operated animals of the same genotype (SH). Contraction of enzymat-
ically isolated left ventricular myocytes was measured during electrical field
stimulation; membrane currents and [Ca2þ]i were measured under whole-cell
patch clamp, with Fluo-3 as Ca2þ indicator, all at 35C. Data are shown as
mean5SEM. Results. In WT, TAC induced an increase in cell width (from
2850.7mm in SH to 3050.9mm in TAC, P<0.05), but not in cell length.
This increase was prevented in TG mice (2850.7mm in SH vs. 2850.8mm
in TAX). At 1 Hz, unloaded cell shortening amplitude was not altered with
TAC in both genotypes. However, the prolongation with TAC of time to
peak (to 6353ms vs. 4952ms, P<0.05) and half-time relaxation (to
9858ms vs. 7753ms, P<0.05) in WT was less in TG (to 5854ms vs.
5554ms for time to peak and 9156ms vs. 8456ms for half-time relaxation).
[Ca2þ]i transient amplitude, L-type Ca
2þ current density and SR Ca2þ content
were unchanged with TAC in both genotypes. RyR spontaneous activity
(sparks) increased with frequency in SH animals. This frequency effect was re-
duced by TAC in WT but not in TG animals (P<0.05). Conclusion. FKBP12.6
overexpression reduces cellular hypertrophy and blunts functional remodeling
in the setting of pressure-overload.
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The cardiac muscle ryanodine receptor-calcium release channel (RyR2)
and its interaction with an accessory protein, FK506-binding protein
(FKBP12.6), have been implicated in the molecular pathogenesis of acquired
and inherited cardiac disease (e.g. catecholaminergic polymorphic ventricular
tachycardia; CPVT). We have assessed the FKBP12.6 binding characteristics
of recombinant wild-type and CPVT mutant RyR2 channels under basal and
oxidising conditions. We find that the R176Q and S2246L mutations exhibit
an increased FKBP12.6 binding by ~40% and ~20% respectively, whereas
R4497C was similar to wild-type. The redox sensitivity of the FKBP12.6
interaction with the mutant RyR2 channels was very similar to wild-type.
The oxidising reagents H2O2 and diamide resulted in reduced FKBP12.6
binding by ~10% and by ~50%, respectively, compared to the untreated state
for all four RyR2 proteins. These results suggest that the FKBP12.6 regula-
tion of RyR2 is unlikely to be defective in inherited arrhythmogenic cardiac
disease.
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Mutant RyR2 responsible for CPVT can trigger on stress and exercise catheco-
laminergic induced-ventricular arrhythmias and sudden death. Defective RyR2,
ubiquitously expressed in the heart, is responsible for sarcoplasmic reticulum
dysfunction that may lead to atrial and ventricular contractile changes also de-
tectable under basal conditions. Left atrial and right ventricular trabeculae were
dissected from control (WT) and heterozygous mice (HE) carrying one of the
most common CPVT-related RyR2 mutations (R4496C). Preparations under-
went various stimulation protocols, including pause-delayed and premature
stimuli while isometric tension was recorded. For intracellular Ca2þ and action
potential recordings ventricular and atrial cardiomyocytes were isolated. In HE
myocytes maximum post-rest increase in the amplitude of intracellular
Ca2þtransients was reduced compared to WT. Maximum post-rest potentiation
of isometric tension was lower in HE than in WT trabeculae (e.g.228537%
vs.386571%, p<0.05, in atrial trabeculae) and was reached at shorter rest-in-
tervals in HE preparations. Steady-state frequency and isoproterenol-induced
positive inotropic responses were less pronounced in HE vs. WT trabeculae.
These results seem consistent with the ‘‘leaky phenotype’’ of the mutant
RyR2. Electrical refractoriness was the same in HE and WT myocytes but in
HE trabeculae mechanical refractoriness was shorter and restitution of isomet-
ric tension was significantly faster than in WT. The rate constant of mechanical
restitution at 1 Hz basal frequency was 10.0751.40 s1 in HE atrial trabeculae
vs. 5.2851.25 s1 in WT and 3.6850.37 s1 in HE ventricular trabeculae
vs. 1.4950.99 s1 in WT (p<0.05). Isoproterenol accelerated mechanical
restitution of all types of trabeculae but did not abolish the difference between
HE and WT preparations. A faster recovery from refractoriness of the mutant
RyR2 may be responsible for these findings. Supported by Telethon-Italy
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A common RyR2 polymorphism (G1885E) modulates the caffeine-sensitivity
of an arrhythmogenic RyR2 mutation (L433P). However, despite the markedly
different caffeine sensitivities that characterised homotetrameric channels
formed from mutant subunits (L433P) or subunits in which the mutation was
complemented in cis with the polymorphism (L433P/G1885E), cells express-
ing these channels exhibited equivalent reductions in the propensity for spon-
taneous intracellular Ca2þ oscillations under non-stimulated conditions. This
finding suggested that a common mechanistic basis of perturbed basal Ca2þ
handling may exist. We explored whether other factors, in addition to altered
agonist sensitivity, contributed to the altered homeostatic Ca2þ signalling in
these cells. We analysed the relationships between the amplitude and kinetic
profiles of caffeine-evoked Ca2þ responses and multiple indices of basal
Ca2þ homeostasis including mean Ca2þ levels, propensity for spontaneous os-
cillation and Ca2þ signal noise. Under non-stimulated conditions, intracellular
Ca2þ signal noise was comparable in cells expressing WT RyR2, L433P,
G1885E or L433P/G1885E. The amplitude and temporal characteristics of caf-
feine-evoked Ca2þ release was linked to basal Ca2þ cycling in cells expressing
WT and G1885E channels. However, in cells expressing L433P the relation-
ships between basal Ca2þ cycling and the amplitude and kinetic profiles of
sub-maximal caffeine-triggered Ca2þ release was significantly altered. Under
these conditions, the sequestration mechanisms that underlie the decay kinetics
of the Ca2þ transients were uncoupled from basal Ca2þ handling events. In cis
complementation with the G1885E polymorphism only partially reversed this
phenomenon. Our data suggest that arrhythmogenic RyR2 mutations may per-
turb the regulatory link between homeostatic Ca2þ cycling events in non-stim-
ulated cells and the cellular Ca2þ response following agonist stimulation. This
functional uncoupling, that was a feature of channels exhibiting very different
caffeine sensitivities, may be an important mechanistic defect that contributes
to dysfunctional Ca2þ release in arrhythmogenesis.
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More than 70 arrhythmia-linked mutations have been identified in the cardiac
ryanodine receptor (RyR2). The observation that different mutations underlie
similar clinical phenotypes supports the concept of a common mechanism of
mutant channel dysfunction. However, RyR2 mutations are not exclusively
‘gain-of-function’ and some mutations may underpin different arrhythmogenic
mechanisms. Additional mechanistic complexity may be conferred by the puta-
tive role of sequence polymorphisms in modulating the clinical severity of
arrhythmias arising from ion channelopathies. A common RyR2 polymorphism
(G1885E), that occurs at a frequency of approximately 6% in normal popula-
tions, is found on the same allele (in cis) as RyR2mutations in symptomatic fam-
ilies (Tiso et al., (2001) Hum. Mol. Genet. 10 189–194). We investigated the
modulatory effects of the G1885E polymorphism on human wild-type (WT)
and L433P mutant channel function. eGFP-taggedWT RyR2, or RyR2 contain-
ing the L433P mutation, G1885E polymorphism or L433P and G1885E in cis
(L433P/G1885E) were expressed in HEK293 cells. Consistent with previous
findings (Thomas et al., (2005)), L433P channels exhibited decreased sensitivity
to caffeine-evoked Ca2þ release although maximal responses were comparable
to WT. Despite a trend toward increased caffeine sensitivity, G1885E channels
were similar to WT. Unexpectedly, complementation of L433P in cis with
G1885E reversed the right-shifted dose response characteristic of L433P chan-
nels and produced channels that exhibited significantly increased caffeine sensi-
tivitywhen compared toWTRyR2.Despite theirmarkedly different sensitivities
to caffeine, cells expressing L433P or L433P/G1885E exhibited a reduced pro-
pensity of spontaneous Ca2þ oscillations under non-stimulated conditions. The
mechanistic basis of these phenomena has been explored.We have extended the
study to examine the functional consequences of L433P and G1885E comple-
mentation in trans. This data provides the first evidence that RyR2 polymor-
phisms may be a critical determinant of mutant channel dysfunction.
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112a Sunday, March 1, 2009Apoptotic cell death is involved in normal and pathologic cardiac function. Ap-
optosis is pivotal in normal developmental cardiogenesis and yet unregulated
cardiomyocyte loss via apoptosis contributes to cardiac degeneration in heart
failure. There is emerging evidence that distinct populations of cardiomyocytes
may exhibit differential susceptibility to apoptosis. We showed that alternative
splicing of the cardiac ryanodine receptor (RyR2) modulated the susceptibility
of cardiomyocytes toCa2þ-linked apoptosis (George et al., (2007)). Specifically,
a 24bp splice variant (encoding VTGSQRSK inserted distal to residue 3715 in
human RyR2) suppressed homeostatic and agonist-evoked Ca2þ fluxes in cardi-
omyocytes. We proposed that alternative splicing of RyR2 may represent
a mechanism for ‘tuning’ pro- and anti-apoptotic Ca2þ fluxes. Our data supports
the concept that the 24bp splice insertion stabilises RyR2-mediated Ca2þ re-
lease, andwe tested this hypothesis using single channel and cellular approaches.
In single channel experiments using CHAPS-solubilised, sucrose gradient-en-
riched preparations incorporated into PE bilayers, we investigated the effects
of synthetic peptides containing VTGSQRSK on the Ca2þ sensitivity of re-
combinant human RyR2 channels devoid of alternatively spliced insertions
(RyR2/). In a complementary approach we used confocal imaging to deter-
mine the effects of these peptides on Ca2þ handling in living cardiomyocytes.
Peptideswere injected into the nucleus and cytoplasmof synchronously-coupled
HL-1 cells (that exclusively express RyR2/) and cellular Ca2þ fluxeswere an-
alysed using the multi-parametric Synchronicity-Amplitude-Length and Vari-
ability of Oscillation (SALVO) program that describes the ‘contractile’ and
‘non-contractile’ aspects of cellular Ca2þ handling. In both approaches, peptides
encoding a splice insertion that did not protect cells from Ca2þ-linked apoptosis
(FAIDSLCGFG), or scrambled sequenceswere used as controls. Our data shows
the utility of these complementary approaches in determining the mechanistic
basis of altered cellular Ca2þ handlingmediated by alternative splicing of RyR2.
574-Pos Board B453
Use Of Shaker B Kþ Channel NH2-inactivation Peptides To Probe The
Ryanodine Receptor Ca2þ Release Channel Pore
Cedric Viero1, Jo Carney1, Sammy Mason1, Mark Bannister2, S R. Chen3,
Alan J. Williams1.
1Wales Heart Research Institute, Cardiff, United Kingdom, 2Boston
Biomedical Research Institute, Watertown, MA, USA, 3Department of
Physiology and Biophysics, Libin Cardiovascular Institute of Alberta,
University of Calgary, Calgary, AB, Canada.
Inactivation of Kþ channels occurs by the interaction of the pore with NH2-ter-
minal sequences. Synthetic peptides corresponding to these sequences were ap-
plied to the purified mouse cardiac ryanodine receptor type 2 (RyR2) and single
channel activity was recorded in planar lipid bilayers. The wild type (WT)
Shaker B NH2-peptide MAAVAGLYGLGEDRQHRKKQ induced a block of
the open RyR2 channel in a concentration and voltage-dependent manner,
but also when the channel displayed a ryanodine-modified state [Mead et al.,
J. Membrane Biol., 1998]. In the latter condition, in a 200 mM KCl buffer
when the holding potential was at þ50 mV, the open probability decreased
by a factor of 2 (p¼0.001, n¼10 channels for control and n¼5 for WT peptide)
mainly due to a 4-fold reduction (p<0.01, n¼10 channels for control and n¼5
for WT peptide) of the mean open time in the presence of 20 mMWT peptide. It
is noteworthy that the peptide at 20 mM had no effect in a 600 mM KCl buffer,
suggesting the importance of charged residues in the blocking effect on RyR2.
Furthermore we designed a mutant peptide where the amino acid Alanine in po-
sitions 3 and 5 was replaced by Glutamine residues, giving a less hydrophobic
feature to the peptide. The mutant peptide at 20 mM in a 200 mM KCl buffer
was less effective than the WT peptide, while showing a different mechanism
of action. These findings are consistent with the idea that RyR2 contains well
organised charged and hydrophobic residues in its conduction pathway and that
they may play a general role in the ion translocation mechanisms of the sarco-
plasmic reticulum Ca2þ release channel.
Acknowledgement: This work is funded by the British Heart Foundation.
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Imperatoxin A (IpTxa) is a 33 amino acid peptide toxin from the African scor-
pion Pandinus imperator. Its definitive structural and functional characteristics
designate it as a member of the calcin family, a unique group of peptide toxins,
which to date includes Hemicalcin (HCa), Hadrucalcin (HdCa), IpTxa, Maur-
ocalcin (MCa), and Opicalcins 1 & 2 (Opi 1 & 2). Calcins are unified by 1)
a compact, globular structure containing an inhibitor cystine knot, 2) positive
net charge, 3) the ability to activate ryanodine receptors (RyR) with high affin-
ity and selectivity, and 4) presumed or confirmed cell-penetrating capabilities.
Previous studies have demonstrated the ability of MCa to carry a fluorescentcargo to the interior of intact cells, and we have used a similar method to con-
firm that IpTxa is also a cell-penetrator. In addition, we have demonstrated
IpTxa’s ability to transiently enhance calcium release from the sarcoplasmic re-
ticulum (SR) of intact cells. In the current study, we used confocal microscopy
to explore the effects of IpTxa on saponin-permeabilized cells. Perfusion of
10nM IpTxa on cells resulted in a dramatic reduction of sparks to as low as
1% of control within two minutes. This effect was even more pronounced
and rapid in the presence of 50nM toxin, with complete ablation of sparks in
less than 1 minute. At the same time, mean fluorescence is often increased in
our scans relative to control, although rapid application of caffeine reveals
that SR calcium content is retained. Our results suggest that IpTxa depletes cal-
cium from the SR, a hypothesis that would explain not only the ablation of
sparks, but also the transient nature of enhanced calcium release in intact cells
observed upon perfusion with IpTxa.
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This study investigates the novel block from the cytosolic face of mRyR2 by
three hERG blocking agents. For this purpose, astemizole (A), terfenadine (T)
and chloroquine (C) were investigated based on their different affinities of
hERG block (IC50 ¼ 0.9 nM, 56–204 nM and 2500 nM) and differences in
their proposed mechanisms of action at the cytosolic face of ion channels.
As well as exhibiting high affinity block of hERG, these blockers exhibit
half maximal block of multiple ion channel types at concentrations exceeding
1  106 M. Whilst mRyR2 lacks the key residues (Y652 and F656) involved
in high affinity block of hERG it does possess a wide pore containing a high
density of hydrophobic residues. Therefore the potential exists for mRyR2,
like hERG, to be blocked by a diverse range of compounds with high affinity.
The aim of this study is to examine the properties/mechanisms of mRyR2
block to identify areas within mRyR2 that may be involved in drug binding.
Similar to their action in non-hERG ion channels, these compounds block
mRyR2 within the micromolar range (IC50; (A) - 16.12 5 2.12 mM; (T) -
30.04 5 4.81 mM and (C) - 17.73 5 5.14 mM; n ¼ 5) at þ 50 mV. Whilst
all blockers reduce the single channel current amplitude to ~ 95 % of control
levels, astemizole and terfenadine induce additional blocking states, whilst
also allowing channel closure during periods of block. Chloroquine exhibits
briefer blocking events, indicating a faster off rate and no additional reduced
conductance states observed. This work was funded by the British Heart
Foundation.
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Consumption of green tea has been found to closely correlate with a lower risk
of heart disease and reduced cardiovascular mortality. Extracted from green
leaves, a group of catechin polyphenols appears to be responsible for these ben-
eficial cardiovascular effects. Studies have shown that epigallocatechin-3-gal-
late (EGCG), one of the most abundant and potent catechins, can modulate
myocardial contractility through some unknown mechanisms. Recent evidence
suggests a role for Naþ/Hþ and Naþ/Ca2þ exchangers in the ionotropic effects
of EGCG in rat heart. Here we report that cardiac Ca2þ release channel - RyR2
serves as a possible molecular target of EGCG that may be responsible for am-
plified Ca2þ transients, enhanced ventricular contractility and increased cell
shortening in cardiac myocytes. In single isolated mouse ventricular myocytes
EGCG (5mM) increased peak systolic Ca2þ transient amplitude, increased de-
cay of the Ca2þ transient, increased fractional shortening and increased con-
traction and relaxation velocities. To assess the direct interaction of EGCG
with RyR2, both purified and membrane-bound RyR2 single channels were re-
constituted in planar lipid bilayers. In the presence of 0.5mM EGCG, the open
probability (Po) increased from Po¼0.012 in the control state to Po¼0.387. Us-
ing [3H]ryanodine as a probe to assess channel conformational states, our data
further indicate that (1) EGCG dose-dependently enhanced junctional SRmem-
brane-bound RyR2 channel activity and (2) EGCG increased Ca2þ-induced
Ca2þ activation of RyR2 (EC50 ¼ 7.0 and 1.7 mM for control and EGCG,
respectively). In summary, our data are consistent with previous reports for
positive inotropic and lusitropic effects by EGCG on heart cells. In addition,
our data clearly supports a role of EGCG in modulating cardiac E-C coupling
through interacting with RyR2 channel complex. Supported by K01 AR51519
to GR and P01 AR52354.
